The regulation of MMP targeting to invadopodia during cancer metastasis by Abitha Jacob & Rytis Prekeris
REVIEW ARTICLE
published: 02 February 2015
doi: 10.3389/fcell.2015.00004
The regulation of MMP targeting to invadopodia during
cancer metastasis
Abitha Jacob and Rytis Prekeris*
Department of Cell and Developmental Biology, School of Medicine, Anschutz Medical Campus, University of Colorado Denver, Aurora, CO, USA
Edited by:




National de la Santé et de la
Recherche Médicale U1048, France
Sébastien Roger, University of
Tours, France
*Correspondence:
Rytis Prekeris, Department of Cell
and Developmental Biology, School
of Medicine, Anschutz Medical
Campus, University of Colorado
Denver, 12801 East 17th Avenue,
Bldg. RC-1, Room L18-12402,
Aurora, CO, USA
e-mail: Rytis.Prekeris@ucdenver.edu
The dissemination of cancer cells from the primary tumor to a distant site, known as
metastasis, is the main cause of mortality in cancer patients. Metastasis is a very complex
cellular process that involves many steps, including the breaching of the basement
membrane (BM) to allow the movement of cells through tissues. The BM breach occurs
via highly regulated and localized remodeling of the extracellular matrix (ECM), which is
mediated by formation of structures, known as invadopodia, and targeted secretion of
matrix metalloproteinases (MMPs). Recently, invadopodia have emerged as key cellular
structures that regulate the metastasis of many cancers. Furthermore, targeting of various
cytoskeletal modulators and MMPs has been shown to play a major role in regulating
invadopodia function. Here, we highlight recent findings regarding the regulation of protein
targeting during invadopodia formation and function.
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INTRODUCTION
Although epithelial cancers are one of the leading causes of death,
the mechanisms regulating the development and metastasis of
carcinomas are not fully understood. Multiple studies suggest
that the progression of tumors is dependent on the intrinsic
properties of cancer cells, such as their ability to migrate and
invade. Furthermore, many extrinsic factors, such as extracellular
matrix (ECM) proteins, are also crucial for regulation of can-
cer metastasis. The ECM proteins that make up the specialized
basement membrane (BM) serve as a barrier for cell invasion.
However, the BM which is rich in laminin and collagen IV, also
provides the substrate for adhesion of the migrating tumor cells.
Furthermore, BM degradation results in the release/activation of
various growth factors required for angiogenesis, tumor growth,
and metastasis (Kalluri, 2003; Yurchenco, 2011). ECM degrading
enzymes known as matrix metalloproteinases (MMPs) are known
to play important roles in the degradation of the BM. Since sev-
eral excellent reviews have already described the importance of
MMPs in cancer cell growth and metastasis (Egeblad and Werb,
2002; Deryugina and Quigley, 2006; Fingleton, 2006; Gialeli et al.,
2011), this review will focus on the mechanisms governing the
targeting of MMPs to invadopodia.
THE ROLE OF THE FAMILY OF MATRIX
METALLOPROTEINASES (MMPs) IN CANCER CELL
METASTASIS
BM disruption involves a localized degradation of the ECM via
the secretion of MMPs (Chamber and Matrisian, 1997). MMPs
are a family of zinc endopeptidases that cleave ECM molecules
and are subdivided into categories depending on their substrate
specificity. The MMP family of enzymes includes not only the
classical secreted and membrane bound MMPs, but also ADAMs
(a disintegrin andmetalloproteinase). ADAMmetalloproteinases,
also known as sheddases, are involved in cleaving various growth
factors, cytokines, receptors, and adhesionmolecules and are fun-
damental to development and homeostasis (Edwards et al., 2008).
Like ADAMs, MMPs are also required for normal processes like
tissue remodeling in embryonic development, wound healing,
involution of mammary glands, angiogenesis, and ossification
(Woessner, 1991). However, high levels of MMPs or aberrant
MMP expression have often been correlated with pathological
conditions like periodontitis, arthritis (Woessner, 1991) and have
been implicated in multiple stages of cancer progression includ-
ing invasion and metastasis (Egeblad and Werb, 2002). In this
review, we will focus on the canonical MMPs, more specifically
the ones that are targeted to the invadopodia and implicated in
BM remodeling during metastasis of epithelial cancers. The asso-
ciation of MMPs with malignancies has been well documented
with the majority of the evidence derived from mouse model
studies and analysis of human patient samples. Based on substrate
recognition, MMPs are categorized into interstitial collagenases,
gelatinases, stromelysins, and membrane bound MMPs. Out of
the 28 known MMPs, 14 have been implicated in cancer devel-
opment and progression (Kohrmann et al., 2009). It has been
shown that elevated expression of MMP1, 2, 3, 7, 9, 13, and
14 is positively correlated with tumor progression, metastasis,
and poor overall prognosis (Lochter et al., 1998; Kerkela and
Saarialho-Kere, 2003; Mook et al., 2004; Wagenaar-Miller et al.,
2004; Ala-aho and Kahari, 2005; Bjorklund and Koivunen, 2005;
Hofmann et al., 2005). Recently, it was shown that MMP9 drives
tumor progression and metastasis of triple negative breast cancer
(Mehner et al., 2014) and increased expression ofMMP9 has been
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found in the early steps of melanoma (van den Oord et al., 1997).
Expression ofMMP9 has been associated both positively and neg-
atively with survival rates in breast and colon cancer patients
(Zeng et al., 1996; Takeha et al., 1997; Pacheco et al., 1998; Scorilas
et al., 2001). Additionally, cancer cells have lesser capability to col-
onize the lungs of MMP2 or MMP9 deficient mice compared to
wild type mice (Itoh et al., 1998, 1999) and cancer cell prolifera-
tion is decreased in tumors obtained fromMMP9 knock-outmice
(Bergers et al., 2000; Coussens et al., 2000). Overexpression of
MMP3 andMMP14 (also known as MT1-MMP) has been shown
to promote mammary carcinogenesis (Sternlicht et al., 1999; Ha
et al., 2001). MMP12 expression in colon cancer has been cor-
related with increased survival (Yang et al., 2001). These studies
indicate that several MMPs play a key role in cancer growth and
metastasis. However, the expression levels and functions of indi-
vidual MMPs are clearly dependent on the stage and type of
cancer.
While MMP expression is increased in many cancers, the
levels of activated rather than total MMPs appear to be a bet-
ter indicator of tumor metastatic potential. There are two main
mechanisms of post transcriptional regulation of MMP activity:
activation of the latent precursor form (zymogen) and inhibi-
tion of the active enzyme by tissue inhibitors of MMPs or tissue
inhibitors of metalloproteinases (TIMPs) (Polette et al., 2004).
Most MMPs are secreted in an inactive pro-enzyme form and
are activated extra-cellularly. An interesting property of MMPs is
that they are capable of mutual activation. For example, MMP1
and MMP14 can activate MMP2 (Murphy and Crabbe, 1995;
Strongin et al., 1995; Sang et al., 1996). The proteolytic activity
of MMPs is also regulated by TIMPs, by binding to the zinc ion
in their catalytic site (Gomis-Ruth et al., 1997; Fernandez-Catalan
et al., 1998). There are four known TIMPs, of which TIMP1 and
TIMP2 are the most promiscuous and inhibit the majority of
MMPs. In vivo studies in mice have shown that overexpression of
TIMP1 decreases metastasis to the brain and to the liver (Soloway
et al., 1996; Kruger et al., 1997, 1998; Sternlicht and Werb, 2001).
Overall, MMP activity is tightly regulated by different mecha-
nisms and is involved in both normal and pathologic processes
(Polette et al., 2004).
THE ROLE OF INVADOPODIA FORMATION DURING CANCER
CELL INVASION
While the mechanisms mediating the movement of cells through
the ECM remain to be fully characterized, it is now widely
accepted that the formation of actin rich invasive protrusions is
a key step during cancer cell invasion. These structures were iden-
tified in tissue culture cells and have been termed as podosomes
or invadopodia (Tarone et al., 1985; Chen, 1989). While the func-
tional differences between podosomes and invadopodia remain
to be clearly defined, recent nomenclature has tried to distin-
guish podosomes as present in normal cells and invadopodia as
present in cancer cells (Murphy and Courtneidge, 2011; Hoshino
et al., 2013). Nevertheless, there are more similarities than dif-
ferences between podosomes and invadopodia. Both these struc-
tures are actin rich and possess the ability to degrade the ECM
(Linder and Kopp, 2005) However, they differ in their size,
number, lifetime and location, which allows for differentiation
between them during visualization (Linder and Kopp, 2005).
Both podosomes and invadopodia are usually visualized with
phalloidin, which stains filamentous actin and appears as punc-
tate spots located below the nucleus. Podosomes have been
observed in cells of monocytic lineage such as macrophages
(Lehto et al., 1982; Linder et al., 1999) osteoclasts (Marchisio
et al., 1984) and in induced smooth muscle cells (Gimona
et al., 2003) as well as endothelial cells (Moreau et al., 2003;
Osiak et al., 2005). In contrast, invadopodia are found in
cells transformed with oncogenes (David-Pfeuty and Singer,
1980; Tarone et al., 1985) and are thought to protrude further
into the matrix and invade more aggressively than podosomes
(Weaver, 2008; Linder et al., 2011; Murphy and Courtneidge,
2011). A variety of actin regulators, scaffold proteins, small
GTPases, and proteinases have been shown to play impor-
tant roles in several steps of invadopodia formation. Several
studies using animal xenografts and primary tumor cells from
patients have also demonstrated the formation of invadopodia
in vivo. Additionally, invadopodia has been observed in bladder
cancer (Sutoh et al., 2010; Yamamoto et al., 2011), colorec-
tal cancer (Schoumacher et al., 2010), breast cancer (Coopman
et al., 1998; Yamaguchi et al., 2005a, 2011) squamous cell car-
cinoma (Takkunen et al., 2010) and glioblastoma (Stylli et al.,
2008).
The ability of invadopodia to degrade ECM is attributed to
the presence of matrix degrading enzymes such as MMPs. While
the cellular machinery mediating the targeted release of MMPs
from invadopodia remains to be defined, it is becoming clear
that some MMPs are targeted and released from invadopodia
to facilitate invasion (Nakahara et al., 1997). MMP14, MMP2,
and MMP9 have all been shown to be important in cancer pro-
gression and enriched at the invadopodia (Monsky et al., 1993;
Nakahara et al., 1997; Bourguignon et al., 1998; Artym et al.,
2006; Clark and Weaver, 2008; Poincloux et al., 2009). MMP2
and MMP9 contain fibronectin repeats that help them recognize
gelatin (denatured collagen) as a substrate (Polette et al., 2004)
and Type IV collagen is the main constituent of the BM, one of
the first barriers that cancer cells need to traverse to metastasize.
In addition, MMP14 can recognize and cleave a broad spectrum
of ECM substrates and also functions as an activator of MMP2
(Lebeau et al., 1999). Thus, the combined activity of MMP2,
MMP9, and MMP14 is suggested to be an important step in ini-
tiating localized degradation of the BM during epithelial cancer
metastasis (Nakahara et al., 1997; Chen and Wang, 1999). Even
though this review focuses on the proteolytic aspect of MMP14,
it is interesting to note that it can also function through a non-
proteolytic mechanism. MMP14 can stimulate ATP production
by activating Hypoxia- Inducible Factor-1(HIF-1) (Sakamoto and
Seiki, 2010). The non-proteolytic activity ofMMP14 also includes
binding of its transmembrane domain to integrin β1, which leads
to MAPK activation, thereby regulating branching in mammary
epithelium (Mori et al., 2013).
Invadopodia formation and function are complex cellu-
lar events that involve substantial reorganization in cytoskele-
ton dynamics and membrane transport. Recent studies have
attempted to define different stages of invadopodia formation and
function by using various criteria, including the recruitment of
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actin, targeted release of MMPs and the localized degradation
of the ECM. Based on these, invadopodia formation has been
divided into three stages, namely, initiation, assembly, and matu-
ration. The following sections describe the stages of invadopodia
formation in detail.
INITIATION
In the initiation phase of invadopodia formation, invadopodial
precursors, or “buds” form at the cell periphery which are usually
marked by actin puncta (Yamaguchi et al., 2005b). The process
of invadopodia formation is initiated by growth factors such as
epidermal growth factor (EGF), platelet derived growth factor
(PDGF) and transforming growth factor- β (TGFβ). Growth fac-
tor receptor signaling activates Phosphatidylinositide 3-Kinase
(P13K) leading to Src activation, which in turn phosphorylates
multiple proteins including Tks5 (Tyrosine kinase substrate).
Since the PX domain (phospholipid binding domain) of Tks5
has been shown to bind to PI3P and PI(3,4)P2 (Abram et al.,
2003), it was suggested that Tks5 localizes to PI(3,4)P2 enriched
regions of the plasma membrane, thus targeting Tks5 to ini-
tiate the invadopodia “bud” (Courtneidge et al., 2005). Src
phosphorylates synaptojanin 2 to activate its phosphatase activ-
ity, which dephosphorylates PI(3,4,5)P3at the plasma membrane
to form PI(3,4)P2, thus forming the site for invadopodia for-
mation (Chuang et al., 2012). Src mediated activation of the
Abl-family kinase Arg also leads to the phosphorylation of cor-
tactin, resulting in the recruitment of Nck1 to the invadopodia
(Oser et al., 2009; Mader et al., 2011). Nck1 then recruits the
Neural Wiskott-Aldrich syndrome protein (N-Wasp) complex to
the invadopodia leading to Cdc42-dependent activation of N-
Wasp. N-Wasp in turn induces actin polymerization through the
Arp2/3 complex, resulting in formation of invadopodial precur-
sors (Yamaguchi et al., 2005a). The co-localization of cortactin
with Tks5 in invadopodial “buds,” led to the hypothesis that Tks5
acts a scaffolding protein that recruits the other cellular compo-
nents required for initiation of invadopodia formation. However,
some recent evidence suggests that Tks5might instead be involved
in invadopodia maturation (Sharma et al., 2013).
ASSEMBLY
Invadopodia are highly dynamic and motile structures that have
been divided into two types based on their motility and life-
times, motile short-lived and stationary long-lived invadopo-
dia (Yamaguchi et al., 2005a). The short-lived invadopodia are
thought to be precursors of fully functional mature invadopo-
dia and could also be equivalent to podosomes (Yamaguchi et al.,
2005a). In vitro, newly formed or early invadopodia can move lat-
erally within the plasma membrane that faces the ECM. These
motile invadopodia are then anchored and stabilized by actin
polymerization and extension of the invadopodia (Yamaguchi
et al., 2005a). A plethora of proteins are recruited to the invadopo-
dial “bud” converting it from motile to stationary invadopodia.
The precise order of how proteins are recruited is still unknown.
Since Tks5 has five tandem SH3 domains, it is thought that Tks5
can scaffold several proteins like Nck1, Nck2, Grb2 (Growth fac-
tor receptor bound protein 2) and N-Wasp. It has also been
proposed that Tks5, along with cortactin, recruits various actin
regulators leading to nucleation of branched actin filaments and
the formation of a stable actin core in the invadopodia (Clark and
Weaver, 2008; Oser et al., 2009). Consistent with this hypothesis,
it has been shown that phosphorylation of cortactin leads to dis-
sociation of the cortactin/cofilin complex, which is an essential
step in invadopodia formation and elongation (Oser et al., 2009).
The dissociation of the cortactin/cofilin complex and the poly-
merization of actin is also a pH-dependent process (Pope et al.,
2004; Frantz et al., 2008).
MATURATION
Actin polymerization is crucial for formation and function of
invadopodia. Inhibition of cofilin results in the formation of
short-lived unstable invadopodia, which suggests that actin poly-
merization caused by cofilin is required for elongation and mat-
uration of invadopodia (Yamaguchi et al., 2005a). Apart from the
branched actin network, invadopodia also contain linear actin
bundles (Li et al., 2010; Schoumacher et al., 2010). mDia2, a
formin that induces the formation of linear actin networks, has
been found to promote elongation and stability of invadopodia
(Lizarraga et al., 2009). Fascin, another actin bundling protein
has also been shown to promote elongation, stability and matrix
degradation in invadopodia (Li et al., 2010; Schoumacher et al.,
2010).
Src kinase is a major regulator of invadopodia formation and
function. Interestingly, several other protein kinases including Abl
kinases like Arg (Abl related gene) kinase have recently emerged
as important players in invadopodia formation and maturation
(Beaty et al., 2013). It was shown that β1 integrin interacts with
Arg leading to stimulation of Arg mediated cortactin phospho-
rylation, a key switch in promoting invadopodial maturation
(Beaty et al., 2013). Additionally, β1 integrin has been shown
to localize to invadopodia and promote degradation of collagen
type IV, the main constituent of the BM (Sameni et al., 2008),
presumably by recruiting and docking proteases at the invadopo-
dia. Separase, a gelatinolytic enzyme that has been shown to be
enriched at the invadopodia, binds to α3β1 integrin resulting in
the formation of functional invadopodia (Mueller et al., 1999).
The ultrastructure of mature invadopodia has shown the pres-
ence of microtubules and many vesicles/endosomes indicative
of active trafficking and a possible route for delivery of spe-
cific proteins like MMPs (Schoumacher et al., 2010). The activity
of proteases docked at the invadopodia has been shown to be
pH-dependent (Greco et al., 2014). Furthermore, it was demon-
strated that the acidification of the peri-invadopodial space by the
Na+/H+ exchanger (NHE1) promotes ECM proteolysis (Busco
et al., 2010).
MECHANISMS MEDIATING MMP TARGETING TO
INVADOPODIA
The final maturation stage of the invadopodia involves targeted
delivery and exocytosis of MMP2, MMP9, and MMP14. The
appearance of these MMPs is generally considered to be a mark
of functional mature invadopodia. As the result, much effort has
been invested in understanding the regulation of MMP targeting
to invadopodia, leading to recent studies defining the machinery
governing MMP transport during cancer cell invasion.
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FIGURE 1 | The schematic representation of the pathways regulating MMP14 (A) and MMP2/9 (B) targeting to the invadopodia.
TARGETING OF MMP14
MMP14 is a membrane embedded MMP whose extracellular
proteolytic activity is regulated by a balance between exocy-
tosis and internalization via clathrin and/or caveolar mediated
endocytosis (Remacle et al., 2003; Figure 1A). Once internal-
ized, MMP14 is then either targeted to lysosomes for degradation
(Jiang et al., 2001; Remacle et al., 2003) or shunted to endo-
cytic recycling pathways, thus controlling the levels of active
enzyme at the cell surface (Remacle et al., 2003; Figure 1A).
However, invasive cancer cells have mechanisms to counteract
the removal of the active enzyme from the plasma membrane.
Consistently, enrichment of active MMP14 at the invadopodia
associated plasma membrane of tumor cells has been demon-
strated in vitro (Nakahara et al., 1997; Artym et al., 2006; Clark
and Weaver, 2008; Steffen et al., 2008). Endocytic recycling
(Poincloux et al., 2009) exocytosis (Monteiro et al., 2013), Rab
8 (Bravo-Cordero et al., 2007) and Tks4 (Buschman et al., 2009)
have all been shown to be involved in the localization of MMP14
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to the invadopodia. However, the exact mechanism governing
MMP14 targeting remains to be fully understood. Rab8 GTPase
has been shown to be involved in mobilization of MMP14 from
intracellular storage compartments allowing polarized recruit-
ment of MMP14 to the invasive front of cells (Bravo-Cordero
et al., 2007). Some of the exocytic components shown to regulate
delivery of MMP14 to the invadopodia are cortactin, the Exocyst
complex (consists of 8 subunits) and VAMP7. Cortactin has been
shown to regulate the cell surface expression of MMP14 (Clark
et al., 2007). Sec8, a subunit of the Exocyst complex, was shown
to localize at the invadopodia and is required for MMP14 target-
ing to the invadopodia (Monteiro et al., 2013; Figure 1A). Active
RhoA and Cdc42 trigger the interaction between the Exocyst
subunits Sec3 and Sec8 and the polarity protein IQGAP1. This
interaction has been shown to be required for the accumulation
of MMP14 at the invadopodia (Sakurai-Yageta et al., 2008). The
Exocyst complex has also been shown to interact with Arp2/3
activator Wiskott-Aldrich syndrome protein and Scar homolog
(WASH) to ensure focal delivery of MMP14 to the invadopo-
dia (Monteiro et al., 2013). Since exocytosis depends on SNAREs
(soluble N-ethylmaleimide sensitive factor attachment protein
receptors) which drive the fusion of transport vesicles with the
plasma membrane, several recent studies have investigated the
role of SNAREs in mediating MMP14 transport. Consequently,
it was shown that VAMP7 (vesicle associated membrane protein
7) is required for trafficking of MMP14 to invadopodia (Steffen
et al., 2008; Figure 1A).
Transport vesicle targeting and fusion with its destination
membranes often relies on specific tethering factors that impart
specificity to membrane transport. The tethering factors reg-
ulating MMP14 targeting remain to be identified. However,
Tks4, a scaffolding factor related to Tks5, has been shown to
be required for the formation and function of invadopodia
(Buschman et al., 2009). In the absence of Tks4, recruitment of
MMP14 to podosomes is inhibited, implicating the role of Tks4
in targeting of MMP14 to the invadopodia (Buschman et al.,
2009; Figure 1A). Additionally, cortactin was reported to have a
novel role in invadopodial maturation and invasion by regulat-
ing secretion of MMP14 at the invadopodia (Clark and Weaver,
2008). However, it remains to be tested whether Tks4 and cor-
tactin function as MMP14-vesicle tethers, or whether they affect
MMP14 targeting indirectly by regulating the actin cytoskeleton
within during invadopodia formation and maturation. Recently,
it was also shown that Orai1 calcium channels can also regu-
late MMP14 targeting, since Orail1-mediated Ca2+ oscillations
regulate MMP14 recycling to the plasma membrane (Sun et al.,
2014).
TARGETING OF MMP2 AND MMP9
MMP2 and MMP9 are gelatinases that possess fibronectin type
II repeats that allow them to degrade collagen and gelatin.
Gelatinolytic degradation can cause the release of signaling
molecules from the ECM that aid cell migration and angiogenesis.
A lot of effort has been focused on understanding the trans-
port and targeting of gelatinases because they are overexpressed
in a variety of tumors and are associated with tumor aggressive-
ness and poor patient prognosis (Pacheco et al., 1998; Egeblad
and Werb, 2002; Hiratsuka et al., 2002; van ’t Veer et al., 2002).
Although MMP2 and MMP9 have been shown to be enriched at
the invadopodia, there is not much known about how these pro-
teases are transported and targeted to the invadopodia. It has been
reported that MMP2 and MMP9 are stored and transported in
small vesicles that move along microtubules powered by kinesin
in human melanoma cells (Schnaeker et al., 2004; Figure 1B).
Similar to MMP14, the secretion of MMP2 and MMP9 were
also shown to depend on cortactin (Clark and Weaver, 2008).
Interestingly, in contrast to MMP14, endocytic transport and the
Exocyst complex do not appear to play a role in targeted transport
of MMP2 and MMP9 (Jacob et al., 2013). Instead, MMP2 and
MMP9 are transported via specialized secretory vesicles directly
from the trans-Golgi Network (TGN) to the invadopodia (Jacob
et al., 2013). While much of the machinery mediating the for-
mation and transport of these secretory vesicles remains to be
defined, it was recently shown that Rab40b GTPase plays an
important role in targeting MMP2/9 to the invadopodia (Jacob
et al., 2013; Figure 1B).
INVADOPODIA FORMATION AND FUNCTION IN VIVO
Although there is an increasing amount of evidence demonstrat-
ing the existence of invadopodia in vitro, the formation and
function of invadopodia in vivo is less well understood due to
challenges associated with visualizing and distinguishing these
structures in animal models. Cancer invasion usually occurs deep
in tissues and these events are highly dynamic and unpredictable
making it difficult to visualize invadopodia during primary tumor
metastasis. Though the majority of invadopodial studies have
been conducted in 2D tissue culture systems, some groups have
studied invadopodia formation in 3D matrices as they better
simulate the physiological in vivo environment. Such studies of
invadopodia in complex 3D matrices have shown that the matrix
degrading activity is localized to the base rather than the tip of
the invadopodia (Wolf et al., 2007; Tolde et al., 2010). These 3D
studies have also helped establish criteria for the identification of
invadopodia in vivo and provide a goodmodel to study formation
of invadopodia.
Despite the challenges mentioned above, there is some com-
pelling evidence drawn from elegant in vivo experiments that
confirm that invadopodia are not just in vitro artifacts. Recently,
the chorioallantoic membrane of the chicken embryo was used
to visualize the intravascular formation of invadopodia and the
extravasation of tumor cells into the stroma (Leong et al., 2014).
The same group also showed that knocking down invadopodial
components like cortactin, Tks4 and Tks5 decreases extravasa-
tion of cells into the lung stroma in tail vein injected mice.
Intravital live animal imaging has also allowed the visualiza-
tion of MtLn3-GFP (a highly invasive rat mammary carcinoma
line) invading into blood vessels using protrusions identified as
invadopodia-like structures using invadopodia markers such as
cortactin and N-WASP (Lohmer et al., 2014). Using live-cell
imaging, it was shown that during the uterine-vulval develop-
ment in Caenorhabditis elegans, the anchor cell breaches the uter-
ine and vulval basementmembranes bymaking an invadopodium
(Hagedorn et al., 2013). The Src-Tks5 pathway was shown to be
required for the migration of neural crest cells using actin-rich
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protrusions in zebrafish (Murphy et al., 2011). Finally, it has
also been shown that the intestinal epithelium of the zebrafish
mutantmeltdown forms invadopodia-like protrusions that invade
into the stromal tissue in response to cues from the surrounding
smooth muscle layer (Seiler et al., 2012).
CONCLUSIONS AND FUTURE DIRECTIONS
Significant advances have been made in understanding the for-
mation and function of invadopodia. However, there are still a
lot more unknowns regarding this subcellular structure. While
all of the above mentioned studies have helped to confirm the
physiological role of invadopodia as a structure used by inva-
sive cells to penetrate the basement membrane, more evidence is
required to elucidate the functional role of invadopodia in vivo
and understand how widespread the use of invadopodia by cells
is. Many questions regarding the importance of invadopodia in
cancer invasion and metastasis still exist. Future studies in the
field of invadopodia will need to focus on detection of invadopo-
dia in human cancer samples as well as to identify the role of
invadopodia in the different steps of the metastatic cascade. The
other areas that require focus are the identification of components
specific to invadopodia that can be targeted and the development
of compounds that can specifically inhibit invadopodia forma-
tion and function. These issues will need to be addressed before
invadopodia can become a candidate for development of new
cancer therapies.
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